BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23720072)

  • 1. Ablation for hepatocellular carcinoma: validating the 3-cm breakpoint.
    Groeschl RT; Gamblin TC; Turaga KK
    Ann Surg Oncol; 2013 Oct; 20(11):3591-5. PubMed ID: 23720072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of survival after resection of early hepatocellular carcinoma.
    Nathan H; Schulick RD; Choti MA; Pawlik TM
    Ann Surg; 2009 May; 249(5):799-805. PubMed ID: 19387322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.
    Waki K; Aikata H; Katamura Y; Kawaoka T; Takaki S; Hiramatsu A; Takahashi S; Toyota N; Ito K; Chayama K
    J Gastroenterol Hepatol; 2010 Mar; 25(3):597-604. PubMed ID: 20074153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma.
    Peng ZW; Zhang YJ; Chen MS; Liang HH; Li JQ; Zhang YQ; Lau WY
    Surg Oncol; 2008 Jul; 17(1):23-31. PubMed ID: 17869095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial.
    Peng ZW; Zhang YJ; Liang HH; Lin XJ; Guo RP; Chen MS
    Radiology; 2012 Feb; 262(2):689-700. PubMed ID: 22157201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of locoregional therapies versus supportive care in maintaining survival within the Milan criteria in patients with hepatocellular carcinoma.
    Dhanasekaran R; Khanna V; Kooby DA; Spivey JR; Parekh S; Knechtle SJ; Carew JD; Kauh JS; Kim HS
    J Vasc Interv Radiol; 2010 Aug; 21(8):1197-204; quiz 204. PubMed ID: 20656222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete tumor encapsulation on magnetic resonance imaging: a potentially useful imaging biomarker for better survival in solitary large hepatocellular carcinoma.
    Lu DS; Siripongsakun S; Kyong Lee J; Wei SH; Cheng PM; Sabounchi S; Lee JS; Raman S; Tong MJ; Busuttil RW; Sayre J
    Liver Transpl; 2013 Mar; 19(3):283-91. PubMed ID: 23280814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryoablation provides superior local control of primary hepatocellular carcinomas of >2 cm compared with radiofrequency ablation and microwave coagulation therapy: an underestimated tool in the toolbox.
    Ei S; Hibi T; Tanabe M; Itano O; Shinoda M; Kitago M; Abe Y; Yagi H; Okabayashi K; Sugiyama D; Wakabayashi G; Kitagawa Y
    Ann Surg Oncol; 2015 Apr; 22(4):1294-300. PubMed ID: 25287439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermal Ablation versus Surgical Resection for the Treatment of Stage T1 Hepatocellular Carcinoma in the Surveillance, Epidemiology, and End Results Database Population.
    Mironov O; Jaberi A; Kachura JR
    J Vasc Interv Radiol; 2017 Mar; 28(3):325-333. PubMed ID: 28073607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined percutaneous radiofrequency ablation and ethanol injection for hepatocellular carcinoma in high-risk locations.
    Wong SN; Lin CJ; Lin CC; Chen WT; Cua IH; Lin SM
    AJR Am J Roentgenol; 2008 Mar; 190(3):W187-95. PubMed ID: 18287411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes after curative treatment for cryptogenic cirrhosis-associated hepatocellular carcinoma satisfying the Milan criteria.
    Takuma Y; Nouso K; Makino Y; Gotoh T; Toshikuni N; Morimoto Y; Shimomura H; Yamamoto H
    J Gastroenterol Hepatol; 2011 Sep; 26(9):1417-24. PubMed ID: 21884248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical outcomes of radiofrequency ablation combined with transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma: a single-center experience].
    Lin JJ; Wu W; Jiang XF; Jin XJ; Lu LJ; Bao LW
    Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):144-7. PubMed ID: 23714672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors.
    Kim YS; Lim HK; Rhim H; Lee MW; Choi D; Lee WJ; Paik SW; Koh KC; Lee JH; Choi MS; Gwak GY; Yoo BC
    J Hepatol; 2013 Jan; 58(1):89-97. PubMed ID: 23023009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamine synthetase immunostaining correlates with pathologic features of hepatocellular carcinoma and better survival after radiofrequency thermal ablation.
    Dal Bello B; Rosa L; Campanini N; Tinelli C; Torello Viera F; D'Ambrosio G; Rossi S; Silini EM
    Clin Cancer Res; 2010 Apr; 16(7):2157-66. PubMed ID: 20233882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database.
    Ding J; Wen Z
    BMC Cancer; 2021 Oct; 21(1):1157. PubMed ID: 34715816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation.
    Komorizono Y; Oketani M; Sako K; Yamasaki N; Shibatou T; Maeda M; Kohara K; Shigenobu S; Ishibashi K; Arima T
    Cancer; 2003 Mar; 97(5):1253-62. PubMed ID: 12599233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm].
    Yang MJ; An SY; Moon EJ; Lee MS; Hwang JA; Cheong JY; Won JH; Kim JK; Wang HJ; Cho SW
    Korean J Hepatol; 2009 Dec; 15(4):474-85. PubMed ID: 20037266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival with up to 10-year follow-up after combination therapy of chemoembolization and radiofrequency ablation for the treatment of hepatocellular carcinoma: single-center experience.
    Fujimori M; Takaki H; Nakatsuka A; Uraki J; Yamanaka T; Hasegawa T; Shiraki K; Takei Y; Sakuma H; Yamakado K
    J Vasc Interv Radiol; 2013 May; 24(5):655-66. PubMed ID: 23428356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous ablative therapies of recurrent hepatocellular carcinoma after hepatectomy: proposal of a prognostic model.
    Yin XY; Xie XY; Lu MD; Kuang M; Liu GJ; Xu ZF; Xu HX; Wang Z
    Ann Surg Oncol; 2012 Dec; 19(13):4300-6. PubMed ID: 22766980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.